Identification | Back Directory | [Name]
7,8-Didehydrocimigenol | [CAS]
150972-72-8 | [Synonyms]
7(8)-Ene-cimigenol 7,8-Didehydrocimigenol (3beta,15alpha,23R,24S)-16,23:16,24-Diepoxycycloart-7-ene-3,15,25-triol 9,19-Cyclolanost-7-ene-3,15,25-triol, 16,23:16,24-diepoxy-, (3β,15α,16α,23R,24S)- (3beta,15alpha,16alpha,23R,24S)-16,23:16,24-Diepoxy-9,19-cyclolanost-7-ene-3,15,25-triol | [Molecular Formula]
C30H46O5 | [MOL File]
150972-72-8.mol | [Molecular Weight]
486.68 |
Hazard Information | Back Directory | [Description]
7,8-Didehydrocimigenol upregulates PPAR-γ in EC inhibits NF-kB activity of TNF-α-activated EC which leads to selective inhibition of VCAM-1 expression.
7,8-Didehydrocimigenol can be used for the treatment of cardiovascular disorders such as atherosclerosis. | [target]
TNF-α | PPAR | NF-kB | ERK | Akt | IkB | IKK |
|
Company Name: |
cjbscvictory
|
Tel: |
13348960310 13348960310 |
Website: |
http://www.weikeqi-biotech.com/ |
|